礼来股价跌近7%,减肥药去年四季度销售增速不及预期

澎湃新闻
15 Jan

手握明星减肥药替尔泊肽的礼来公布了2024年第四季度预期收入,由于不及此前财务指引而股价下跌明显。  当地时间1月14日,美国礼来公司(LLY.US)发布消息称,公司预计2024年全年全球收入约为450亿美元,同比增长32%,其中第四季度预计全球收入约为135亿美元,比2023年第四季度增长45%。此外,礼来还预计,2025年的销售额将在580亿美元至610亿美元之间,同比增长最低达到28.88%...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10